Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) Moat Score: 0/10 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08049 Jilin Province Huinan Changlong Bio-pharmacy Co Ltd HKSE:08049
80 GF Score
Price HK$2.38
GF Value HK$1.66
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Jilin Province Huinan Changlong Bio-pharmacy Co Moat Score?

Jilin Province Huinan Changlong Bio-pharmacy Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Jilin Province Huinan Changlong Bio-pharmacy Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Jilin Province Huinan Changlong Bio-pharmacy Co might have No Moat - No discernible moat.

Jilin Province Huinan Changlong Bio-pharmacy Co  (HKSE:08049) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Jilin Province Huinan Changlong Bio-pharmacy Co Moat Score Related Terms

HKSE:08049
80GF Score
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd HKSE:08049
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Jilin Province Huinan Changlong Bio-pharmacy Co (HKSE:08049) Overvalued in 2026?

Based on GuruFocus' analysis, Jilin Province Huinan Changlong Bio-pharmacy Co stock appears to be overvalued. The current stock price of HK$2.38 is trading 43.4% above its estimated GF Value™ of HK$1.66. GuruFocus considers Jilin Province Huinan Changlong Bio-pharmacy Co to be Significantly Overvalued.

Key valuation signals for HKSE:08049:

  • Moat Score: 0
  • GF Value™: HK$1.66 vs. price of HK$2.38 (43.4% above fair value)
  • GF Score™: 80/100 with 5 warning signs

No single metric tells the full story. See the HKSE:08049 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jilin Province Huinan Changlong Bio-pharmacy Co Business Description

Other Exchanges JIL:Germany
Address 625 & 639 Nathan Road, Room 1101-2, 11th Floor, Office Tower Two, Grand Plaza, Mong kok, Kowloon, Hong Kong, HKG
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products in the PRC under the brand names of Changlong and Qing Tong. The company has only one business segment. It generates revenue from the Sales of Chinese medicines and pharmaceutical products. Geographically, it derives its entire revenue from the PRC.
80GF Score

Get the complete analysis for HKSE:08049

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.38
Price
HK$1.66
GF Value